$1.620
+0.383 (+23.66%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
¿Debería comprar acciones de Davion Healthcare Plc Ordinary Shares?
Daviion Healthcare Plc is not a good buy right now due to its significant decline in value and lack of positive financial indicators. The stock has dropped 89.17% year-to-date and is currently trading at $1.49, which is very close to its 52-week low of $1.46. Additionally, the company has a price-to-book ratio of 31.6019, indicating it is highly overvalued compared to its assets. The recent acquisitions may provide some future potential, but the current performance and high risk outweigh these factors.
DAVI cerró en $1.62 el Friday, tras subir +23.66%
Davion Healthcare Plc Ordinary Shares (DAVI) last closed at $1.62, gaining +23.66%. These facts feed the 1-day and 1-week DAVI price prediction above.
Factores de la previsión
Los factores de la previsión de Davion Healthcare Plc Ordinary Shares (DAVI) combinan patrones gráficos similares, estacionalidad y medias móviles.
Seasonality
Bearish
Análisis de estacionalidad de DAVI
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.